CL2008003536A1 - Composicion farmaceutica oftalmica u otica que consiste en a) moxifloxacina, b) fosfato de dexametasona o una sal equivalente, c) edetato disodico, d) cloruro de sodio, e) acido borico, f) sorbitol o cloruro de benzalconio, g) surfactante no-ionico, h) ajustador de ph, i) agua, util para el tratamiento de infecciones. - Google Patents
Composicion farmaceutica oftalmica u otica que consiste en a) moxifloxacina, b) fosfato de dexametasona o una sal equivalente, c) edetato disodico, d) cloruro de sodio, e) acido borico, f) sorbitol o cloruro de benzalconio, g) surfactante no-ionico, h) ajustador de ph, i) agua, util para el tratamiento de infecciones.Info
- Publication number
- CL2008003536A1 CL2008003536A1 CL2008003536A CL2008003536A CL2008003536A1 CL 2008003536 A1 CL2008003536 A1 CL 2008003536A1 CL 2008003536 A CL2008003536 A CL 2008003536A CL 2008003536 A CL2008003536 A CL 2008003536A CL 2008003536 A1 CL2008003536 A1 CL 2008003536A1
- Authority
- CL
- Chile
- Prior art keywords
- moxifloxacin
- ophthalmic
- adjuster
- sorbitol
- ionic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composición farmacéutica oftálmica u ótica que consiste en a) moxifloxacina, b) fosfato de dexametasona o una sal equivalente, c) edetato disódico, d) cloruro de sodio, e) ácido bórico, f) sorbitol o cloruro de benzalconio, g) surfactante no-iónico, h) ajustador de ph, i) agua, útil para el tratamiento de infecciones.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99045207P | 2007-11-27 | 2007-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008003536A1 true CL2008003536A1 (es) | 2009-10-16 |
Family
ID=40467276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008003536A CL2008003536A1 (es) | 2007-11-27 | 2008-11-27 | Composicion farmaceutica oftalmica u otica que consiste en a) moxifloxacina, b) fosfato de dexametasona o una sal equivalente, c) edetato disodico, d) cloruro de sodio, e) acido borico, f) sorbitol o cloruro de benzalconio, g) surfactante no-ionico, h) ajustador de ph, i) agua, util para el tratamiento de infecciones. |
Country Status (16)
Country | Link |
---|---|
US (2) | US7888370B2 (es) |
EP (1) | EP2211835A1 (es) |
JP (1) | JP2011504881A (es) |
KR (1) | KR20100090278A (es) |
CN (1) | CN101861139A (es) |
AR (1) | AR069438A1 (es) |
AU (1) | AU2008329876A1 (es) |
BR (1) | BRPI0819908A2 (es) |
CA (1) | CA2703913A1 (es) |
CL (1) | CL2008003536A1 (es) |
MX (1) | MX2010004953A (es) |
RU (1) | RU2010126096A (es) |
TW (1) | TW200932285A (es) |
UY (1) | UY31494A1 (es) |
WO (1) | WO2009070530A1 (es) |
ZA (1) | ZA201002884B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
WO2013065028A1 (en) * | 2011-11-04 | 2013-05-10 | Micro Labs Limited | Fixed dose combination containing azithromycin and loteprednol for treatment of ocular infections |
ITMI20122002A1 (it) * | 2012-11-26 | 2014-05-27 | Farmacologico Milanese Srl Lab | Preparazioni farmaceutiche liquide stabilizzate |
RU2662067C2 (ru) * | 2013-01-31 | 2018-07-23 | Сэндзю Фармасьютикал Ко., Лтд. | Прозрачный водный раствор |
US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
US10130639B1 (en) * | 2015-09-05 | 2018-11-20 | Randal Davis | Homogeneous ophthalmic composition |
US11452732B2 (en) * | 2015-09-05 | 2022-09-27 | Randal Davis | Homogeneous ophthalmic composition |
GR1008921B (el) * | 2015-12-10 | 2017-01-12 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον δεξαμεθαζονη |
JP6694525B2 (ja) * | 2016-05-06 | 2020-05-13 | ハーロウ・ヘルス・インコーポレイテッドHarrow Health, Inc. | 薬学的眼病用組成物およびそれを製造するための方法 |
US20190216830A1 (en) * | 2017-10-06 | 2019-07-18 | Aciont Inc. | Ophthalmic compositions |
CN113750041A (zh) * | 2020-06-04 | 2021-12-07 | 成都倍特药业股份有限公司 | 一种地塞米松磷酸钠液体制剂及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2939873A (en) * | 1959-01-26 | 1960-06-07 | Merck & Co Inc | Synthesis of steroid phosphates |
US5414011A (en) * | 1987-09-11 | 1995-05-09 | Syntex (U.S.A.) Inc. | Preservative system for ophthalmic formulations |
US5407926A (en) * | 1987-12-29 | 1995-04-18 | Alcon Laboratories, Inc. | Ophthalmic composition |
DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
IL102414A (en) * | 1991-07-25 | 1996-08-04 | Univ Louisville Res Found | Medicinal preparations for the treatment of ocular inflammation, containing rapamycin |
ES2079994B1 (es) * | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
US6740664B2 (en) * | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
US6716830B2 (en) * | 1998-09-30 | 2004-04-06 | Alcon, Inc. | Ophthalmic antibiotic compositions containing moxifloxacin |
WO2001089495A2 (en) | 2000-05-19 | 2001-11-29 | Alcon Laboratories, Inc. | Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose |
-
2008
- 2008-11-24 BR BRPI0819908-6A patent/BRPI0819908A2/pt not_active IP Right Cessation
- 2008-11-24 CN CN200880116678A patent/CN101861139A/zh active Pending
- 2008-11-24 WO PCT/US2008/084532 patent/WO2009070530A1/en active Application Filing
- 2008-11-24 RU RU2010126096/15A patent/RU2010126096A/ru unknown
- 2008-11-24 KR KR1020107011695A patent/KR20100090278A/ko not_active Application Discontinuation
- 2008-11-24 US US12/276,823 patent/US7888370B2/en active Active
- 2008-11-24 EP EP08855506A patent/EP2211835A1/en not_active Withdrawn
- 2008-11-24 MX MX2010004953A patent/MX2010004953A/es not_active Application Discontinuation
- 2008-11-24 CA CA2703913A patent/CA2703913A1/en not_active Abandoned
- 2008-11-24 JP JP2010535114A patent/JP2011504881A/ja not_active Withdrawn
- 2008-11-24 AU AU2008329876A patent/AU2008329876A1/en not_active Abandoned
- 2008-11-26 TW TW097145700A patent/TW200932285A/zh unknown
- 2008-11-27 AR ARP080105164A patent/AR069438A1/es not_active Application Discontinuation
- 2008-11-27 UY UY31494A patent/UY31494A1/es not_active Application Discontinuation
- 2008-11-27 CL CL2008003536A patent/CL2008003536A1/es unknown
-
2010
- 2010-04-23 ZA ZA2010/02884A patent/ZA201002884B/en unknown
- 2010-12-14 US US12/967,250 patent/US8173671B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN101861139A (zh) | 2010-10-13 |
RU2010126096A (ru) | 2012-01-10 |
US20090137539A1 (en) | 2009-05-28 |
US7888370B2 (en) | 2011-02-15 |
JP2011504881A (ja) | 2011-02-17 |
AR069438A1 (es) | 2010-01-20 |
AU2008329876A1 (en) | 2009-06-04 |
MX2010004953A (es) | 2010-08-10 |
KR20100090278A (ko) | 2010-08-13 |
ZA201002884B (en) | 2011-07-27 |
CA2703913A1 (en) | 2009-06-04 |
BRPI0819908A2 (pt) | 2015-05-19 |
US20110082125A1 (en) | 2011-04-07 |
TW200932285A (en) | 2009-08-01 |
WO2009070530A1 (en) | 2009-06-04 |
US8173671B2 (en) | 2012-05-08 |
UY31494A1 (es) | 2009-03-02 |
EP2211835A1 (en) | 2010-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008003536A1 (es) | Composicion farmaceutica oftalmica u otica que consiste en a) moxifloxacina, b) fosfato de dexametasona o una sal equivalente, c) edetato disodico, d) cloruro de sodio, e) acido borico, f) sorbitol o cloruro de benzalconio, g) surfactante no-ionico, h) ajustador de ph, i) agua, util para el tratamiento de infecciones. | |
CY1121583T1 (el) | Πολυμορφικες και ψευδοπολυμορφικες μορφες της φαρμακευτικης ενωσης nxl104 | |
PH12018501807A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseas | |
NI201600036A (es) | Pesticidas de azoles bicíclicos sustituidos con heterociclos | |
CL2012002422A1 (es) | Método para tratar artritis por lupus activo que comprende administrar al paciente laquinimod o su sal sódica por vía oral. | |
MX2019010446A (es) | Compuestos de anillos fusionados biciclicos derivados de piridilo como inhibidores de fgfr4. | |
CR11151A (es) | Sales del inhibidor de janus cinasa (r)-3-(4-(7h-pirrolo[2,3-ciclopentilpropanitrilo | |
BR112013024933A2 (pt) | sistema tampão para purificação de proteínas | |
EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
IL172513A0 (en) | Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation | |
BR112013021136A2 (pt) | sistema e método para controle sincronizado de uma ceifeira e veículo de transporte | |
CL2007002705A1 (es) | Composicion farmaceutica oftalmica autopreservada que comprende 0,04 a 0,9 mm de iones zinc donde la concentracion de aniones tamponantes es menor que 15 mm. | |
EP4227304A3 (en) | Thiadiazole analogs and their use for treating diseases associated with a deficiency of smn motor neurons | |
BRPI0407658A (pt) | derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico | |
PH12015501752B1 (en) | Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors | |
GT201200181A (es) | Formas cristalinas de 3-(2,6-dicloro-3,5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il}-fenil-amino]-pirimidin-4-il]-1-metil-urea y sales de las mismas | |
GT201300123A (es) | Sal(es) de dimetil-amida del acido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-(2,3-d)-pirimidin-6-carboxilico y procesos para su elaboracion | |
UY34723A (es) | ?compuestos de 7-oxo-1,6-diazabiciclo[3.2.1]oct-3-en-6-ilo sustituidos para usarse como inhibidores de la betalactamasa?. | |
DOP2011000102A (es) | Compuestos heteroaromaticos espirociclicos fusionados para el tratamiento de infecciones bacterianas | |
ES2531093T3 (es) | Procedimiento de preparación de halogenuros de N-alquil-naltrexona | |
SV2017005597A (es) | Compuestos inhibidores de la señalizacion de la via de notch | |
ECSP088532A (es) | Formulación de suspensión de fexofenadina | |
BR112019005318A2 (pt) | compostos de aza-indazol para uso em lesões no tendão e/ou ligamento | |
AR109621A1 (es) | Formulaciones de vacunas contra glucoconjugados de expec | |
BR112015024938A2 (pt) | formulação, uso de formulações, e, processo para preparação de formulações |